Randomised controlled trial
Leyden et al. — clindamycin/BPO vs monotherapies
Leyden JJ et al., Journal of Drugs in Dermatology, 2006;5(1):37–42
- Participants
- 287
- Duration
- 10 weeks
- Comparator
- Clindamycin alone, BPO alone, vehicle
In patients with moderate-to-severe inflammatory acne, once-daily fixed combination clindamycin 1% / BPO 5% produced greater reductions in inflammatory lesion counts than either monotherapy and vehicle. Trial results do not predict individual outcomes.

